Nebulised heparin for patients with or at risk of acute respiratory distress syndrome: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial

Citation

Dixon, B, Smith, R, Campbell, D et al. 2021, 'Nebulised heparin for patients with or at risk of acute respiratory distress syndrome: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial', The Lancet Respiratory Medicine, vol. 9, no. 4, pp. 360-372.

Year

2021

Field of Research

  • Intensive Care

Updated:  23 January 2022 / Responsible Officer:  Director (Research Services Division) / Page Contact:  Researchers